Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Veeva Systems (VEEV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Veeva Systems — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.96 (market cap $1.74B), while Veeva Systems trades at $289.1 (market cap $46.12B). The key difference: Veeva Systems is far larger — about 26.5× Nuvation Bio Inc. Class A Common Stock's market cap, and Veeva Systems is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Veeva Systems for 5 Days on average.
| NUVB | VEEV | |
|---|---|---|
Market Cap | $1.74B | $46.12B |
Volume | 9,289,619 | 921,537 |
Sector | Health | Technology |
52-Week High | $9.54 | $299.10 |
52-Week Low | $3.41 | $151.43 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $1.33B | $39.03B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Veeva Systems
Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →
